Published by Gbaf News
Posted on December 30, 2010

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
Published by Gbaf News
Posted on December 30, 2010

World Bank Group President Robert B. Zoellick today signed a US$30 million credit at Lusaka’s Kalingalinga Township to provide additional financing for the country’s efforts to overcome malaria. This additional credit to support the ongoing Malaria Booster Program was approved by the World Bank’s Board of Executive Directors last week, and will help to maintain and scale up the successes of the first phase of the program.
“Resources from the Malaria Booster Program have contributed to a sharp decline in annual mortality due to malaria as well as to the strengthening of Zambia’s health system,” Zoellick said.“But despite major advances in malaria prevention, the disease remains endemic and is still a leading cause of death, especially among children. We must persist with strong prevention efforts and ensure that health systems are equipped to treat the disease quickly.”
Between 2006 and 2009, Zambia stepped up its efforts to overcome malaria with the support of the World Bank. Preventive measures, including indoor residual spraying and distribution of insecticide treated nets, were particularly effective.
These measures have contributed to dramatic progress against malaria in Zambia during the past decade. The annual number of malaria deaths fell by at least half from 2000 to 2008, during which time the population grew by nearly a third. This implies a reduction in the death rate from malaria of more than 60 percent. Child mortality fell by 29 percent in this period—an estimated 75,000 children’s lives saved in six years.
Speaking in Lusaka’s during a two-day visit to Zambia, Zoellick said the World Bank is proud to have been associated with this success story, through its close cooperation with the Zambian government and other partners that include USAID; the Global Fund; the President’s Malaria Initiative; the Malaria Control and Evaluation Partnership in Africa, and the UN Special Envoy for Malaria, Ray Chambers.
Zoellick explained that the World Bank funds will support the government’s efforts to address remaining challenges, particularly the funding gap for purchases of bed nets. Bed net ownership has declined markedly since 2008 in two of the three provinces that have shown a recent worrying resurgence in malaria.
The $30 million credit will be accompanied by a World Bank grant of US$16.76 million from the Health Results Innovation Trust Fund (HRITF) to strengthen Zambia’s health system and improve the delivery of maternal and child health services in the country’s rural areas. HRITF is a multi-donor trust fund supported by the governments of Norway and the United Kingdom through 2022.
MALARIA IN ZAMBIA: KEY FACTS AND RESULTS